PriMera Scientific Medicine and Public Health (ISSN: 2833-5627)

E-Book

Volume 5 Issue 5

Evaluation of Mpox Surveillance System in Imo State, South-eastern Nigeria

Okoroama Chibuzo Linda, Wadzingi Williams-Bassi, Angela Izegbune, Adeniran Adeniyi Ayobami*, Aibinuomo Ayomide Oluwaseyi, Eronini Ebubechi C, Alfred Ineife, Victor Nnawuba Iheyi, Nosike Job Chibuzo, Ogah Ikechukwu Alo, Akakuru Kingsley Ogbonnaya, Awah Chukwuma Quintus, Egbuna Hyacinth Chukwuebuka, Ihemba Vivian Ngozi, Chinyere Maureen Obejili-Ezeh, Ihedioha Leonard, Stan-Ekezie Ijeoma Doris, Ugo Enebeli, Kalu Ugonna Anthony, Inumanye N Ojule, Okoroama Emeka Casmir and Ihedioha Anthony

October 30, 2024

DOI : 10.56831/PSMPH-05-173

View PDF

Abstract

Public health surveillance is the ongoing, systematic collection, analysis, interpretation, and dissemination of data regarding a health-related event for use in taking public health action geared towards the reduction of morbidity and mortality associated with the disease or health-related event [1].

Data disseminated by a public health surveillance system can be used for immediate public health action, program planning and evaluation, and formulating research hypotheses [1]. Periodic evaluation of public health surveillance systems ensures that problems of public health importance are being monitored efficiently and effectively [1].

Human Mpox is a zoonotic smallpox-like illness caused by the Mpox virus [2, 3]. The Mpox disease (formerly monkeypox) is caused by the Mpox virus (MPXV), an enveloped double-stranded DNA virus of the Orthopoxvirus genus in the Poxviridae family, with two genetic clades, clades I and II [3].

References

  1. Koplan JP., et al. Centers for Disease Control and Prevention Director This report was produced as an MMWR serial publication in Epidemiology Program Office Visual Information Specialist.
  2. Besombes C., et al. “National Monkeypox Surveillance, Central African Republic, 2001-2021”. Emerg Infect Dis 28.12 (2022): 2435.
  3. Monkeypox Public Health Response Guidelines.
  4. Alakunle E., et al. “Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution”. Viruses 12.11 (2020): 1257.
  5. Alakunle E., et al. “Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution”. Viruses 12.11 (2020): 1257.
  6. Surveillance, case investigation and contact tracing for Monkeypox.
  7. A brief history of monkeypox in Nigeria (2022). https://www.idsociety.org/science-speaks-blog/2022/a-brief-history-of-monkeypox-in-nigeria/#/+/0/publishedDate_na_dt/desc/
  8. Arotolu TE., et al. “Spatial modeling and ecological suitability of monkeypox disease in Southern Nigeria”. PLoS One 17.9 (2022): e0274325.
  9. Case Definitions† for Use in the 2022 Mpox Response | Mpox | Poxvirus | CDC (2023).
  10. Surveillance, case investigation and contact tracing for Monkeypox: Interim guidance (2024). https://www.who.int/publications/i/item/WHO-MPX-Surveillance-2022.4
  11. AfricaCDC: Centres for disease control and prevention; Mpox Surveillance: Reporting protocol for African Union member States; Safeguarding Africa’s Health (2024).
  12. Moyo E., et al. “Monkeypox outbreak: a perspective on Africa's diagnostic and containment capacity”. Int J Infect Dis 123 (2022): 127-130.
  13. World Health Organization (2024); Surveillance, case investigation and contact tracing for Mpox (monkeypox). Interim guidance (2024).